Latest Estriol Stories

-- Keynote Speaker, Rhonda R. Voskuhl, M.D., Director of the Multiple Sclerosis Program at UCLA, to Address the Role of Estriol in the Treatment of Multiple Sclerosis -- ROCKVILLE, Md., June 13, 2013 /PRNewswire/ -- Synthetic Biologics, Inc. (NYSE MKT: SYN), a developer of biologics focused on the prevention and treatment of serious infectious diseases, announced today that it will host a Multiple Sclerosis-Estriol Investor Day on Tuesday, June 25, 2013 from 9:00 a.m. to 11:00 a.m....

ANN ARBOR, Mich., March 14, 2012 /PRNewswire/ -- Synthetic Biologics, Inc. (NYSE Amex: SYN), a developer of synthetic DNA-based therapeutics and innovative disease-modifying medicines for serious illnesses, announced today that patient enrollment has been completed in a Phase II clinical trial evaluating the efficacy and safety of Synthetic Biologics' proprietary oral formulation of estriol (Trimesta(TM)) for the treatment of relapsing-remitting multiple sclerosis (MS). With over $8...

ANN ARBOR, Mich., Nov. 9, 2011 /PRNewswire/ -- Adeona Pharmaceuticals, Inc. (AMEX: AEN), a developer of innovative medicines for serious central nervous system diseases, announced today that it will hold its third quarter 2011 investor conference call on Monday, November 14, 2011, at 2:00pm EST. James S. Kuo, M.D., M.B.A., Adeona's Chief Executive Officer, will provide an overview of the Company's multiple sclerosis (MS), ALS and Alzheimer's clinical development programs and...

The School of Business at the Portland State University and Salimetrics, LLC are collaborating to present a lecture-based “Spit Camp Workshop,” which will be held at the Portland State University on November 16th, 2011. Faculty and students who are interested in learning more about the basics of incorporating salivary analytes into their research are invited to attend this free presentation. State College, PA (PRWEB) November 06, 2011 Researchers in the Portland, Oregon area...

The USF College of Nursing and Salimetrics, LLC are collaborating to present a lecture-based “Spit Camp Workshop,” which will be held at the University of South Florida, College of Nursing, on October 6th, 2011. Faculty and students who are interested in learning more about the basics of incorporating salivary analytes into their research are invited to attend this free presentation. State College, Pennsylvania (PRWEB) September 22, 2011 Researchers in the southern Florida...

ANN ARBOR, Mich., Sept. 19, 2011 /PRNewswire/ -- Adeona Pharmaceuticals, Inc. (AMEX: AEN), a developer of innovative medicines for serious central nervous system diseases, announced today that the 150th patient has been enrolled in the randomized, double-blind, placebo-controlled, multi-center clinical trial of its Trimesta(TM) (oral estriol) drug candidate for relapsing-remitting multiple sclerosis (MS) in women, per the original protocol. The Company also announced that Rhonda Voskuhl,...

ANN ARBOR, Mich., May 10, 2011 /PRNewswire/ -- Adeona Pharmaceuticals, Inc. (AMEX:AEN), a developer of innovative medicines for serious central nervous system diseases, announced today that it will hold its 1st quarter 2011 investor conference call on Tuesday, May 17, 2011, at 1:00pm EDT. James S. Kuo, M.D., M.B.A., Adeona's Chief Executive Officer, will host the call. The Company will be joined by special guest, Rhonda Voskuhl, M.D., Director, University of California, Los Angeles (UCLA)...

The addition of a "genetic sonogram" maximizes the accuracy of non-invasive testing for Down syndrome, said a Baylor College of Medicine researcher who was lead author of a landmark study in the current issue of Obstetrics and Gynecology."We wanted to be able to definitively describe the detection and accuracy of noninvasive prenatal screening for the detection of Down syndrome," said Dr. Kjersti Aagaard, assistant professor of obstetrics and gynecology at BCM and the...

FORT LAUDERDALE, Fla., Sept. 10 /PRNewswire/ -- Life Extension(R), the company that long ago sounded the alarm on the dangers of synthetic hormone replacement therapy for menopausal women, has published still more proof that bioidentical hormones offer a far safer treatment option. A white paper entitled Bioidentical Hormones: Why Is There Still a Controversy, published in the October edition of Life Extension Magazine, provides compelling scientific evidence on the safety and...

The relationship between two different types of estrogen and a hormone produced in the placenta may serve as the mechanism for signaling labor, according to a new study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM). This finding may help doctors intervene and prevent preterm birth much more effectively."The trigger for the onset of labor in women has been a puzzle for a long time," says Dr. Roger Smith, MD, PhD, of John...